C12N 2710/00063
By chemical treatment
Official title: by chemical treatment
C12N2710/00063 (By chemical treatment) appears on 3 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 9
- Assignees
- 5
- Inventors
- 20
- Latest grant
- 28 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product28 Apr 2026US 12,612,603 B2Boehringer Ingelheim International GmbH
- Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product15 Aug 2023US 11,725,191 B2Boehringer Ingelheim International GmbH
- Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product8 Oct 2019US 10,435,670 B2Boehringer Ingelheim International GmbH
- Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product13 Aug 2026US 2026/0234572 A1Boehringer Ingelheim International GmbH
- Method for inactivating enveloped viruses9 Jul 2026US 2026/0191191 A1Merck Patent GmbH
- Culture method for fish cells and cell culture medium used therein, and oral vaccine for fish22 Jan 2026US 2026/0021174 A1Bio Science Co., Ltd.
- Mutant nudivirus insect control27 Nov 2025US 2025/0361493 A1University of Kentucky Research Foundation
- Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product26 Oct 2023US 2023/0340425 A1Boehringer Ingelheim International GmbH
Most cited
By later US patents
- Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product5US 10,435,670 B2Boehringer Ingelheim International GmbH · 2019
- Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product1US 11,725,191 B2Boehringer Ingelheim International GmbH · 2023